{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:46:14Z","timestamp":1793655974477,"version":"4.5.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Nutr"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder pathologically characterized by brain parenchymal abundance of amyloid-beta (A\u03b2) and the accumulation of lipofuscin material that is rich in neutral lipids. However, the mechanisms for aetiology of AD are presently not established. There is increasing evidence that metabolism of lipoprotein-A\u03b2 in blood is associated with AD risk, via a microvascular axis that features breakdown of the blood-brain barrier, extravasation of lipoprotein-A\u03b2 to brain parenchyme and thereafter heightened inflammation. A peripheral lipoprotein-A\u03b2\/capillary axis for AD reconciles alternate hypotheses for a vascular, or amyloid origin of disease, with amyloidosis being probably consequential. Dietary fats may markedly influence the plasma abundance of lipoprotein-A\u03b2 and by extension AD risk. Similarly, apolipoprotein E (Apo E) serves as the primary ligand by which lipoproteins are cleared from plasma via high-affinity receptors, for binding to extracellular matrices and thereafter for uptake of lipoprotein-A\u03b2 via resident inflammatory cells. The epsilon <jats:italic>APOE \u03b54<\/jats:italic> isoform, a major risk factor for AD, is associated with delayed catabolism of lipoproteins and by extension may increase AD risk due to increased exposure to circulating lipoprotein-A\u03b2 and microvascular corruption.<\/jats:p>","DOI":"10.1186\/s12263-023-00722-5","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T10:02:48Z","timestamp":1677319368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Peripheral metabolism of lipoprotein-amyloid beta as a risk factor for Alzheimer\u2019s disease: potential interactive effects of APOE genotype with dietary fats"],"prefix":"10.1186","volume":"18","author":[{"given":"Zachary J.","family":"D\u2019Alonzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Takechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nesbit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Vaccarezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C. L.","family":"Mamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"key":"722_CR1","unstructured":"(WHO) WHO. Dementia 2022 [cited 2022 6 April]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"issue":"5","key":"722_CR2","doi-asserted-by":"publisher","first-page":"e12802","DOI":"10.1111\/acel.12802","volume":"17","author":"X Xia","year":"2018","unstructured":"Xia X, Jiang Q, McDermott J, Han JJ. Aging and Alzheimer's disease: comparison and associations from molecular to system level. Aging Cell. 2018;17(5):e12802.","journal-title":"Aging Cell"},{"key":"722_CR3","doi-asserted-by":"publisher","first-page":"9234105","DOI":"10.1155\/2018\/9234105","volume":"2018","author":"MY Cui","year":"2018","unstructured":"Cui MY, Lin Y, Sheng JY, Zhang X, Cui RJ. Exercise intervention associated with cognitive improvement in Alzheimer's disease. Neural Plast. 2018;2018:9234105.","journal-title":"Neural Plast"},{"issue":"2","key":"722_CR4","doi-asserted-by":"publisher","first-page":"e0170547","DOI":"10.1371\/journal.pone.0170547","volume":"12","author":"JK Morris","year":"2017","unstructured":"Morris JK, Vidoni ED, Johnson DK, Van Sciver A, Mahnken JD, Honea RA, et al. Aerobic exercise for Alzheimer's disease: a randomized controlled pilot trial. PLoS One. 2017;12(2):e0170547.","journal-title":"PLoS One"},{"issue":"3","key":"722_CR5","first-page":"204","volume":"6","author":"GY Cao","year":"2019","unstructured":"Cao GY, Li M, Han L, Tayie F, Yao SS, Huang Z, et al. Dietary fat intake and cognitive function among older populations: a systematic review and meta-analysis. J Prev Alzheimers Dis. 2019;6(3):204\u201311.","journal-title":"J Prev Alzheimers Dis"},{"issue":"5","key":"722_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3945\/an.116.012138","volume":"7","author":"SD Petersson","year":"2016","unstructured":"Petersson SD, Philippou E. Mediterranean diet, cognitive function, and dementia: a systematic review of the evidence. Adv Nutr. 2016;7(5):889\u2013904.","journal-title":"Adv Nutr"},{"issue":"2","key":"722_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13668-019-0271-4","volume":"8","author":"AM McGrattan","year":"2019","unstructured":"McGrattan AM, McGuinness B, McKinley MC, Kee F, Passmore P, Woodside JV, et al. Diet and inflammation in cognitive ageing and Alzheimer's disease. Curr Nutr Rep. 2019;8(2):53\u201365.","journal-title":"Curr Nutr Rep"},{"key":"722_CR8","doi-asserted-by":"publisher","first-page":"109420","DOI":"10.1016\/j.cellsig.2019.109420","volume":"64","author":"R Havekes","year":"2019","unstructured":"Havekes R, Heckman PRA, Wams EJ, Stasiukonyte N, Meerlo P, Eisel ULM. Alzheimer's disease pathogenesis: the role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes. Cell Signal. 2019;64:109420.","journal-title":"Cell Signal"},{"issue":"17","key":"722_CR9","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.1073\/pnas.1721694115","volume":"115","author":"E Shokri-Kojori","year":"2018","unstructured":"Shokri-Kojori E, Wang GJ, Wiers CE, Demiral SB, Guo M, Kim SW, et al. \u03b2-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci U S A. 2018;115(17):4483\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"722_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 2016;8(6):595\u2013608.","journal-title":"EMBO Mol Med"},{"key":"722_CR11","doi-asserted-by":"crossref","unstructured":"Moreno-Garc\u00eda A, Kun A, Calero O, Medina M, Calero M. An overview of the role of lipofuscin in age-related neurodegeneration. Front Neurosci. 2018;12:464.","DOI":"10.3389\/fnins.2018.00464"},{"issue":"1","key":"722_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10072-018-3620-y","volume":"40","author":"Y Lin","year":"2019","unstructured":"Lin Y, Shan P-Y, Jiang W-J, Sheng C, Ma L. Subjective cognitive decline: preclinical manifestation of Alzheimer\u2019s disease. Neurol Sci. 2019;40(1):41\u20139.","journal-title":"Neurol Sci"},{"issue":"1","key":"722_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-020-00395-3","volume":"15","author":"X Wang","year":"2020","unstructured":"Wang X, Huang W, Su L, Xing Y, Jessen F, Sun Y, et al. Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer\u2019s disease. Mol Neurodegener. 2020;15(1):55.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"722_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","volume":"15","author":"A Vergallo","year":"2019","unstructured":"Vergallo A, M\u00e9gret L, Lista S, Cavedo E, Zetterberg H, Blennow K, et al. Plasma amyloid \u03b2 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease. Alzheimers Dement. 2019;15(6):764\u201375.","journal-title":"Alzheimers Dement"},{"issue":"7691","key":"722_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dore V, et al. High performance plasma amyloid-beta biomarkers for Alzheimer's disease. Nature. 2018;554(7691):249\u201354.","journal-title":"Nature."},{"issue":"9","key":"722_CR16","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/brain\/awab163","volume":"144","author":"JB Pereira","year":"2021","unstructured":"Pereira JB, Janelidze S, Stomrud E, Palmqvist S, van Westen D, Dage JL, et al. Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects. Brain. 2021;144(9):2826\u201336.","journal-title":"Brain."},{"issue":"15","key":"722_CR17","doi-asserted-by":"publisher","first-page":"e1580","DOI":"10.1212\/WNL.0000000000009240","volume":"94","author":"JD Doecke","year":"2020","unstructured":"Doecke JD, P\u00e9rez-Grijalba V, Fandos N, Fowler C, Villemagne VL, Masters CL, et al. Total A\u03b2 42\/A\u03b2 40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis. Neurology. 2020;94(15):e1580.","journal-title":"Neurology."},{"issue":"17","key":"722_CR18","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, et al. High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology. 2019;93(17):e1647\u2013e59.","journal-title":"Neurology."},{"issue":"1","key":"722_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3233\/JAD-131802","volume":"40","author":"A Rembach","year":"2014","unstructured":"Rembach A, Watt AD, Wilson WJ, Villemagne VL, Burnham SC, Ellis KA, et al. Plasma amyloid-beta levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden. J Alzheimers Dis. 2014;40(1):95\u2013104.","journal-title":"J Alzheimers Dis"},{"key":"722_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.dadm.2017.07.004","volume":"8","author":"N Fandos","year":"2017","unstructured":"Fandos N, P\u00e9rez-Grijalba V, Pesini P, Olmos S, Bossa M, Villemagne VL, et al. Plasma amyloid \u03b2 42\/40 ratios as biomarkers for amyloid \u03b2 cerebral deposition in cognitively normal individuals. Alzheimer's Dement. 2017;8:179\u201387.","journal-title":"Alzheimer's Dement"},{"issue":"9","key":"722_CR21","doi-asserted-by":"publisher","first-page":"e3001358","DOI":"10.1371\/journal.pbio.3001358","volume":"19","author":"V Lam","year":"2021","unstructured":"Lam V, Takechi R, Hackett MJ, Francis R, Bynevelt M, Celliers LM, et al. Synthesis of human amyloid restricted to liver results in an Alzheimer disease\u2013like neurodegenerative phenotype. PLoS Biol. 2021;19(9):e3001358.","journal-title":"PLoS Biol"},{"issue":"3","key":"722_CR22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/hep4.1609","volume":"5","author":"CR Bosoi","year":"2021","unstructured":"Bosoi CR, Vandal M, Tournissac M, Leclerc M, Fanet H, Mitchell PL, et al. High-fat diet modulates hepatic amyloid \u03b2 and cerebrosterol metabolism in the triple transgenic mouse model of Alzheimer\u2019s disease. Hepatol Commun. 2021;5(3):446\u201360.","journal-title":"Hepatol Commun"},{"issue":"2","key":"722_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s12640-016-9682-9","volume":"31","author":"W-S Jin","year":"2017","unstructured":"Jin W-S, Bu X-L, Liu Y-H, Shen L-L, Zhuang Z-Q, Jiao S-S, et al. Plasma amyloid-beta levels in patients with different types of cancer. Neurotox Res. 2017;31(2):283\u20138.","journal-title":"Neurotox Res"},{"issue":"9","key":"722_CR24","doi-asserted-by":"publisher","first-page":"e0203659","DOI":"10.1371\/journal.pone.0203659","volume":"13","author":"CL Maarouf","year":"2018","unstructured":"Maarouf CL, Walker JE, Sue LI, Dugger BN, Beach TG, Serrano GE. Impaired hepatic amyloid-beta degradation in Alzheimer\u2019s disease. PLoS One. 2018;13(9):e0203659.","journal-title":"PLoS One"},{"issue":"3","key":"722_CR25","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/nn4058215","volume":"8","author":"Q Song","year":"2014","unstructured":"Song Q, Huang M, Yao L, Wang X, Gu X, Chen J, et al. Lipoprotein-based nanoparticles rescue the memory loss of mice with Alzheimer\u2019s disease by accelerating the clearance of amyloid-beta. ACS Nano. 2014;8(3):2345\u201359.","journal-title":"ACS Nano"},{"issue":"51","key":"722_CR26","doi-asserted-by":"publisher","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","volume":"271","author":"AL Biere","year":"1996","unstructured":"Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem. 1996;271(51):32916\u201322.","journal-title":"J Biol Chem"},{"issue":"2","key":"722_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0009-8981(97)00207-6","volume":"270","author":"AR Koudinov","year":"1998","unstructured":"Koudinov AR, Berezov TT, Kumar A, Koudinova NV. Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids. Clin Chim Acta. 1998;270(2):75\u201384.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"722_CR28","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1006\/bbrc.1994.2788","volume":"205","author":"A Koudinov","year":"1994","unstructured":"Koudinov A, Matsubara E, Frangione B, Ghiso J. The soluble form of Alzheimer\u2032 s amyloid \u03b2 protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem Biophys Res Commun. 1994;205(2):1164\u201371.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"722_CR29","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.neurobiolaging.2003.10.004","volume":"25","author":"E Matsubara","year":"2004","unstructured":"Matsubara E, Sekijima Y, Tokuda T, Urakami K, Amari M, Shizuka-Ikeda M, et al. Soluble Abeta homeostasis in AD and DS: impairment of anti-amyloidogenic protection by lipoproteins. Neurobiol Aging. 2004;25(7):833\u201341.","journal-title":"Neurobiol Aging"},{"key":"722_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1476-511X-8-46","volume":"8","author":"S Galloway","year":"2009","unstructured":"Galloway S, Takechi R, Pallebage-Gamarallage MM, Dhaliwal SS, Mamo JC. Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine. Lipids Health Dis. 2009;8:46.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"722_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12944-019-1162-9","volume":"18","author":"S Galloway","year":"2019","unstructured":"Galloway S, Takechi R, Nesbit M, Pallebage-Gamarallage MM, Lam V, Mamo JCL. The differential effects of fatty acids on enterocytic abundance of amyloid-beta. Lipids Health Dis. 2019;18(1):209.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"722_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000235555","volume":"90","author":"YH Lee","year":"2009","unstructured":"Lee YH, Martin JM, Maple RL, Tharp WG, Pratley RE. Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals. Neuroendocrinology. 2009;90(4):383\u201390.","journal-title":"Neuroendocrinology."},{"issue":"7","key":"722_CR33","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1038\/oby.2008.267","volume":"16","author":"YH Lee","year":"2008","unstructured":"Lee YH, Tharp WG, Maple RL, Nair S, Permana PA, Pratley RE. Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity (Silver Spring). 2008;16(7):1493\u2013500.","journal-title":"Obesity (Silver Spring)"},{"issue":"Pt 4","key":"722_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1258\/acb.2008.007214","volume":"45","author":"JC Mamo","year":"2008","unstructured":"Mamo JC, Jian L, James AP, Flicker L, Esselmann H, Wiltfang J. Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment. Ann Clin Biochem. 2008;45(Pt 4):395\u2013403.","journal-title":"Ann Clin Biochem"},{"issue":"23","key":"722_CR35","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1212\/WNL.0b013e318258f7c2","volume":"78","author":"Y Gu","year":"2012","unstructured":"Gu Y, Schupf N, Cosentino S, Luchsinger J, Scarmeas N. Nutrient intake and plasma \u03b2-amyloid. Neurology. 2012;78(23):1832\u201340.","journal-title":"Neurology."},{"issue":"2","key":"722_CR36","doi-asserted-by":"publisher","first-page":"111","DOI":"10.4103\/0975-9476.159073","volume":"6","author":"S Subash","year":"2015","unstructured":"Subash S, Essa MM, Braidy N, Awlad-Thani K, Vaishnav R, Al-Adawi S, et al. Diet rich in date palm fruits improves memory, learning and reduces beta amyloid in transgenic mouse model of Alzheimer's disease. J Ayurveda Integr Med. 2015;6(2):111.","journal-title":"J Ayurveda Integr Med"},{"issue":"1","key":"722_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.nbd.2006.06.007","volume":"24","author":"BL Burgess","year":"2006","unstructured":"Burgess BL, McIsaac SA, Naus KE, Chan JY, Tansley GH, Yang J, et al. Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer\u2019s disease mouse models with abundant A\u03b2 in plasma. Neurobiol Dis. 2006;24(1):114\u201327.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"722_CR38","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.cger.2018.06.012","volume":"34","author":"SS Mu\u00f1oz Fern\u00e1ndez","year":"2018","unstructured":"Mu\u00f1oz Fern\u00e1ndez SS, Lima Ribeiro SM. Nutrition and Alzheimer disease. Clin Geriatr Med. 2018;34(4):677\u201397.","journal-title":"Clin Geriatr Med"},{"issue":"2","key":"722_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2217\/nmt-2020-0023","volume":"11","author":"LB Martins","year":"2021","unstructured":"Martins LB, Malheiros Silveira AL, Teixeira AL. The link between nutrition and Alzheimer's disease: from prevention to treatment. Neurodegener Dis Manag. 2021;11(2):155\u201366.","journal-title":"Neurodegener Dis Manag"},{"key":"722_CR40","doi-asserted-by":"crossref","unstructured":"Romanenko M, Kholin V, Koliada A, Vaiserman A. Nutrition, gut microbiota, and Alzheimer's disease. Front Psychiatry. 2021;12:712673.","DOI":"10.3389\/fpsyt.2021.712673"},{"issue":"3","key":"722_CR41","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3945\/ajcn.2009.27725","volume":"91","author":"PW Siri-Tarino","year":"2010","unstructured":"Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91(3):535\u201346.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"722_CR42","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s11745-010-3393-4","volume":"45","author":"R Micha","year":"2010","unstructured":"Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids. 2010;45(10):893\u2013905.","journal-title":"Lipids."},{"issue":"7","key":"722_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/gps.1969","volume":"23","author":"MH Eskelinen","year":"2008","unstructured":"Eskelinen MH, Ngandu T, Helkala EL, Tuomilehto J, Nissinen A, Soininen H, et al. Fat intake at midlife and cognitive impairment later in life: a population-based CAIDE study. Int J Geriatr Psychiatry. 2008;23(7):741\u20137.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9","key":"722_CR44","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2174\/1567205015666180427142350","volume":"15","author":"Y Ruan","year":"2018","unstructured":"Ruan Y, Tang J, Guo X, Li K, Li D. Dietary fat intake and risk of Alzheimer's disease and dementia: a meta-analysis of cohort studies. Curr Alzheimer Res. 2018;15(9):869\u201376.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"722_CR45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000093478","volume":"22","author":"MH Laitinen","year":"2006","unstructured":"Laitinen MH, Ngandu T, Rovio S, Helkala EL, Uusitalo U, Viitanen M, et al. Fat intake at midlife and risk of dementia and Alzheimer's disease: a population-based study. Dement Geriatr Cogn Disord. 2006;22(1):99\u2013107.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"11","key":"722_CR46","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.neurobiolaging.2005.09.026","volume":"27","author":"V Solfrizzi","year":"2006","unstructured":"Solfrizzi V, Colacicco AM, D'Introno A, Capurso C, Torres F, Rizzo C, et al. Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian longitudinal study on aging. Neurobiol Aging. 2006;27(11):1694\u2013704.","journal-title":"Neurobiol Aging"},{"key":"722_CR47","doi-asserted-by":"publisher","first-page":"111355","DOI":"10.1016\/j.nut.2021.111355","volume":"90","author":"R-z Zhu","year":"2021","unstructured":"Zhu R-z, Chen M-q, Zhang Z-w, Wu T-y, Zhao W-H. Dietary fatty acids and risk for Alzheimer's disease, dementia, and mild cognitive impairment: a prospective cohort meta-analysis. Nutrition. 2021;90:111355.","journal-title":"Nutrition."},{"issue":"5","key":"722_CR48","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1017\/S0007114509992194","volume":"103","author":"R Takechi","year":"2010","unstructured":"Takechi R, Galloway S, Pallebage-Gamarallage MM, Wellington CL, Johnsen RD, Dhaliwal SS, et al. Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta. Br J Nutr. 2010;103(5):652\u201362.","journal-title":"Br J Nutr"},{"issue":"2","key":"722_CR49","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/0304-3940(92)90531-B","volume":"134","author":"Y Namba","year":"1992","unstructured":"Namba Y, Tsuchiya H, Ikeda K. Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease. Neurosci Lett. 1992;134(2):264\u20136.","journal-title":"Neurosci Lett"},{"issue":"1","key":"722_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1146\/annurev.ne.19.030196.000413","volume":"19","author":"WJ Strittmatter","year":"1996","unstructured":"Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci. 1996;19(1):53\u201377.","journal-title":"Annu Rev Neurosci"},{"issue":"5123","key":"722_CR51","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"E Corder","year":"1993","unstructured":"Corder E, Saunders A, Strittmatter W, Schmechel D, Gaskell P, Small G, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921\u20133.","journal-title":"Science."},{"key":"722_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2377-8-9","volume":"8","author":"SB Sando","year":"2008","unstructured":"Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, et al. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from Central Norway. BMC Neurol. 2008;8:9.","journal-title":"BMC Neurol"},{"issue":"15","key":"722_CR53","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1021\/acschemneuro.1c00295","volume":"12","author":"E Angelopoulou","year":"2021","unstructured":"Angelopoulou E, Paudel YN, Papageorgiou SG, Piperi C. APOE genotype and Alzheimer\u2019s disease: the influence of lifestyle and environmental factors. ACS Chem Neurosci. 2021;12(15):2749\u201364.","journal-title":"ACS Chem Neurosci"},{"issue":"4852","key":"722_CR54","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science (New York, NY). 1988;240(4852):622\u201330.","journal-title":"Science (New York, NY)"},{"issue":"42","key":"722_CR55","doi-asserted-by":"publisher","first-page":"40723","DOI":"10.1074\/jbc.M304814200","volume":"278","author":"H Saito","year":"2003","unstructured":"Saito H, Dhanasekaran P, Baldwin F, Weisgraber KH, Phillips MC, Lund-Katz S. Effects of polymorphism on the lipid interaction of human apolipoprotein E. J Biol Chem. 2003;278(42):40723\u20139.","journal-title":"J Biol Chem"},{"issue":"3","key":"722_CR56","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0022-2275(20)41527-5","volume":"33","author":"E Campos","year":"1992","unstructured":"Campos E, Nakajima K, Tanaka A, Havel RJ. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res. 1992;33(3):369\u201380.","journal-title":"J Lipid Res"},{"issue":"36","key":"722_CR57","doi-asserted-by":"publisher","first-page":"22453","DOI":"10.1016\/S0021-9258(18)45726-2","volume":"265","author":"KH Weisgraber","year":"1990","unstructured":"Weisgraber KH, Mahley RW, Kowal RC, Herz J, Goldstein JL, Brown MS. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. J Biol Chem. 1990;265(36):22453\u20139.","journal-title":"J Biol Chem"},{"issue":"25","key":"722_CR58","doi-asserted-by":"publisher","first-page":"14791","DOI":"10.1074\/jbc.271.25.14791","volume":"271","author":"CNR Patrick","year":"1996","unstructured":"Patrick CNR, Theo JCvB. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo. J Biol Chem. 1996;271(25):14791.","journal-title":"J Biol Chem"},{"key":"722_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41586-020-2247-3","volume":"581","author":"A Montagne","year":"2020","unstructured":"Montagne A, Nation D, Sagare A, Barisano G, Sweeney M, Chakhoyan A, et al. APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:1\u20136.","journal-title":"Nature."},{"issue":"8","key":"722_CR60","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","volume":"25","author":"C-C Liu","year":"2022","unstructured":"Liu C-C, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, et al. Peripheral apoE4 enhances Alzheimer\u2019s pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci. 2022;25(8):1020\u201333.","journal-title":"Nat Neurosci"},{"issue":"1","key":"722_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1172\/JCI118408","volume":"97","author":"N Bergeron","year":"1996","unstructured":"Bergeron N, Havel RJ. Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele. J Clin Invest. 1996;97(1):65\u201372.","journal-title":"J Clin Invest"},{"issue":"1","key":"722_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/CIRCRESAHA.119.315506","volume":"126","author":"PR Souza","year":"2020","unstructured":"Souza PR, Marques RM, Gomez EA, Colas RA, De Matteis R, Zak A, et al. Enriched marine oil supplements increase peripheral blood specialized pro-resolving mediators concentrations and reprogram host immune responses: a randomized double-blind placebo-controlled study. Circ Res. 2020;126(1):75\u201390.","journal-title":"Circ Res"},{"key":"722_CR63","doi-asserted-by":"crossref","unstructured":"Ravaut G, L\u00e9giot A, Bergeron KF, Mounier C. Monounsaturated fatty acids in obesity-related inflammation. Int J Mol Sci. 2020;22(1):330.","DOI":"10.3390\/ijms22010330"},{"issue":"5","key":"722_CR64","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1152\/japplphysiol.01438.2005","volume":"100","author":"JS Lee","year":"2006","unstructured":"Lee JS, Pinnamaneni SK, Eo SJ, Cho IH, Pyo JH, Kim CK, et al. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J Appl Physiol. 2006;100(5):1467\u201374.","journal-title":"J Appl Physiol"},{"issue":"3","key":"722_CR65","doi-asserted-by":"publisher","first-page":"e92255","DOI":"10.1371\/journal.pone.0092255","volume":"9","author":"F Nardi","year":"2014","unstructured":"Nardi F, Lipina C, Magill D, Hage Hassan R, Hajduch E, Gray A, et al. Enhanced insulin sensitivity associated with provision of mono and polyunsaturated fatty acids in skeletal muscle cells involves counter modulation of PP2A. PLoS One. 2014;9(3):e92255.","journal-title":"PLoS One"},{"issue":"8","key":"722_CR66","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/1028415X.2016.1180859","volume":"20","author":"SM Abdel-Maksoud","year":"2017","unstructured":"Abdel-Maksoud SM, Hassanein SI, Gohar NA, Attia SMM, Gad MZ. Investigation of brain-derived neurotrophic factor (BDNF) gene expression in hypothalamus of obese rats: modulation by omega-3 fatty acids. Nutr Neurosci. 2017;20(8):443\u20138.","journal-title":"Nutr Neurosci"},{"issue":"9","key":"722_CR67","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s00213-019-05258-4","volume":"236","author":"T Pawe\u0142czyk","year":"2019","unstructured":"Pawe\u0142czyk T, Grancow-Grabka M, Trafalska E, Szemraj J, \u017burner N, Pawe\u0142czyk A. An increase in plasma brain derived neurotrophic factor levels is related to n-3 polyunsaturated fatty acid efficacy in first episode schizophrenia: secondary outcome analysis of the OFFER randomized clinical trial. Psychopharmacology. 2019;236(9):2811\u201322.","journal-title":"Psychopharmacology"},{"issue":"12","key":"722_CR68","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1523\/JNEUROSCI.4225-04.2005","volume":"25","author":"GP Lim","year":"2005","unstructured":"Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci. 2005;25(12):3032\u201340.","journal-title":"J Neurosci"},{"issue":"12","key":"722_CR69","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jnutbio.2015.07.022","volume":"26","author":"H Qosa","year":"2015","unstructured":"Qosa H, Mohamed LA, Batarseh YS, Alqahtani S, Ibrahim B, LeVine H 3rd, et al. Extra-virgin olive oil attenuates amyloid-\u03b2 and tau pathologies in the brains of TgSwDI mice. J Nutr Biochem. 2015;26(12):1479\u201390.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"722_CR70","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41398-018-0293-5","volume":"8","author":"SR Rainey-Smith","year":"2018","unstructured":"Rainey-Smith SR, Gu Y, Gardener SL, Doecke JD, Villemagne VL, Brown BM, et al. Mediterranean diet adherence and rate of cerebral A\u03b2-amyloid accumulation: data from the Australian imaging, biomarkers and lifestyle study of ageing. Transl Psychiatry. 2018;8(1):238.","journal-title":"Transl Psychiatry"},{"issue":"3","key":"722_CR71","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/alz.12421","volume":"18","author":"S Hoscheidt","year":"2022","unstructured":"Hoscheidt S, Sanderlin AH, Baker LD, Jung Y, Lockhart S, Kellar D, et al. Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: a randomized trial. Alzheimers Dement. 2022;18(3):457\u201368.","journal-title":"Alzheimers Dement"},{"key":"722_CR72","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1179\/1476830511Y.0000000011","volume":"14","author":"A Sanchez-Villegas","year":"2011","unstructured":"Sanchez-Villegas A, Galbete C, Mart\u00ednez-Gonz\u00e1lez M, Alfredo M, Razquin C, Salas-Salvad\u00f3 J, et al. The effect of the Mediterranean diet on plasma brain-derived neurotrophic factor (BDNF) levels: the PREDIMED-NAVARRA randomized trial. Nutr Neurosci. 2011;14:195\u2013201.","journal-title":"Nutr Neurosci"},{"issue":"7","key":"722_CR73","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1111\/j.1460-9568.2004.03246.x","volume":"19","author":"A Wu","year":"2004","unstructured":"Wu A, Ying Z, Gomez-Pinilla F. The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur J Neurosci. 2004;19(7):1699\u2013707.","journal-title":"Eur J Neurosci"},{"key":"722_CR74","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bbi.2020.06.010","volume":"89","author":"MJ Butler","year":"2020","unstructured":"Butler MJ, Cole RM, Deems NP, Belury MA, Barrientos RM. Fatty food, fatty acids, and microglial priming in the adult and aged hippocampus and amygdala. Brain Behav Immun. 2020;89:145\u201358.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"722_CR75","doi-asserted-by":"publisher","first-page":"2000379","DOI":"10.1002\/mnfr.202000379","volume":"65","author":"W-K Shin","year":"2021","unstructured":"Shin W-K, Shin S, Lee J-k, Kang D, Lee JE. Carbohydrate intake and hyperlipidemia among population with high-carbohydrate diets: the health examinees gem study. Mol Nutr Food Res. 2021;65(3):2000379.","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"722_CR76","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/07315724.2006.10719527","volume":"25","author":"Y Ma","year":"2006","unstructured":"Ma Y, Li Y, Chiriboga DE, Olendzki BC, Hebert JR, Li W, et al. Association between carbohydrate intake and serum lipids. J Am Coll Nutr. 2006;25(2):155\u201363.","journal-title":"J Am Coll Nutr"},{"issue":"3","key":"722_CR77","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1017\/S0029665199000750","volume":"58","author":"MJ Richard","year":"1999","unstructured":"Richard MJ, Roussel AM. Micronutrients and ageing: intakes and requirements. Proc Nutr Soc. 1999;58(3):573\u20138.","journal-title":"Proc Nutr Soc"},{"key":"722_CR78","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.trci.2018.09.002","volume":"5","author":"C Colizzi","year":"2019","unstructured":"Colizzi C. The protective effects of polyphenols on Alzheimer's disease: a systematic review. Alzheimers Dement (N Y). 2019;5:184\u201396.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"722_CR79","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/biology11020212","volume":"11","author":"P Pritam","year":"2022","unstructured":"Pritam P, Deka R, Bhardwaj A, Srivastava R, Kumar D, Jha AK, et al. Antioxidants in Alzheimer&rsquo;s disease: current therapeutic significance and future prospects. Biology. 2022;11(2):212.","journal-title":"Biology."},{"issue":"9","key":"722_CR80","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jalz.2015.04.011","volume":"11","author":"MC Morris","year":"2015","unstructured":"Morris MC, Tangney CC, Wang Y, Sacks FM, Barnes LL, Bennett DA, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015;11(9):1015\u201322.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"722_CR81","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ana.23944","volume":"74","author":"T Psaltopoulou","year":"2013","unstructured":"Psaltopoulou T, Sergentanis TN, Panagiotakos DB, Sergentanis IN, Kosti R, Scarmeas N. Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol. 2013;74(4):580\u201391.","journal-title":"Ann Neurol"},{"issue":"16","key":"722_CR82","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1212\/WNL.0000000000000884","volume":"83","author":"CC Tangney","year":"2014","unstructured":"Tangney CC, Li H, Wang Y, Barnes L, Schneider JA, Bennett DA, et al. Relation of DASH- and Mediterranean-like dietary patterns to cognitive decline in older persons. Neurology. 2014;83(16):1410\u20136.","journal-title":"Neurology."}],"container-title":["Genes &amp; Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12263-023-00722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12263-023-00722-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12263-023-00722-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T11:02:49Z","timestamp":1677322969000},"score":1,"resource":{"primary":{"URL":"https:\/\/genesandnutrition.biomedcentral.com\/articles\/10.1186\/s12263-023-00722-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["722"],"URL":"https:\/\/doi.org\/10.1186\/s12263-023-00722-5","relation":{},"ISSN":["1555-8932","1865-3499"],"issn-type":[{"value":"1555-8932","type":"print"},{"value":"1865-3499","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"9 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}